Analysts Set Xylem Inc. (NYSE:XYL) Price Target at $135.44

Shares of Xylem Inc. (NYSE:XYL) have been given an average rating of “Moderate Buy” by the eleven ratings firms that are presently covering the firm, Marketbeat.com reports. Three analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 12-month price objective among brokerages that have covered the stock in the last year is $135.44.

XYL has been the topic of a number of analyst reports. Raymond James raised Xylem from an “underperform” rating to a “market perform” rating in a research note on Thursday, January 4th. Robert W. Baird increased their price objective on Xylem from $141.00 to $148.00 and gave the company an “outperform” rating in a research note on Thursday, March 21st. Citigroup increased their price objective on Xylem from $126.00 to $139.00 and gave the company a “neutral” rating in a research note on Monday, April 8th. Royal Bank of Canada increased their price objective on Xylem from $140.00 to $145.00 and gave the company an “outperform” rating in a research note on Wednesday, February 7th. Finally, Stifel Nicolaus increased their price objective on Xylem from $136.00 to $150.00 and gave the company a “buy” rating in a research note on Wednesday, February 7th.

Xylem Trading Up 0.6 %

Shares of XYL stock opened at $128.02 on Friday. Xylem has a fifty-two week low of $87.59 and a fifty-two week high of $130.86. The stock has a market cap of $31.03 billion, a P/E ratio of 47.07, a P/E/G ratio of 2.55 and a beta of 1.10. The business has a fifty day simple moving average of $126.79 and a 200-day simple moving average of $111.91. The company has a quick ratio of 1.30, a current ratio of 1.76 and a debt-to-equity ratio of 0.22.

Xylem (NYSE:XYL) last announced its quarterly earnings results on Tuesday, February 6th. The industrial products company reported $0.99 earnings per share for the quarter, beating analysts’ consensus estimates of $0.96 by $0.03. Xylem had a return on equity of 9.65% and a net margin of 8.27%. The business had revenue of $2.12 billion during the quarter, compared to analysts’ expectations of $2.05 billion. During the same quarter last year, the business posted $0.92 earnings per share. The business’s revenue for the quarter was up 40.6% on a year-over-year basis. On average, analysts forecast that Xylem will post 4.13 earnings per share for the current fiscal year.

Xylem Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 20th. Shareholders of record on Wednesday, February 21st were paid a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a yield of 1.12%. This is a positive change from Xylem’s previous quarterly dividend of $0.33. The ex-dividend date of this dividend was Tuesday, February 20th. Xylem’s dividend payout ratio (DPR) is presently 52.94%.

Insiders Place Their Bets

In other news, SVP Franz Cerwinka sold 2,408 shares of the firm’s stock in a transaction dated Thursday, February 8th. The stock was sold at an average price of $121.79, for a total value of $293,270.32. Following the transaction, the senior vice president now directly owns 11,750 shares in the company, valued at approximately $1,431,032.50. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other news, CAO Geri-Michelle Mcshane sold 1,000 shares of the firm’s stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total value of $122,890.00. Following the transaction, the chief accounting officer now directly owns 2,935 shares in the company, valued at approximately $360,682.15. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, SVP Franz Cerwinka sold 2,408 shares of the firm’s stock in a transaction dated Thursday, February 8th. The stock was sold at an average price of $121.79, for a total value of $293,270.32. Following the completion of the transaction, the senior vice president now owns 11,750 shares in the company, valued at $1,431,032.50. The disclosure for this sale can be found here. 0.27% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Xylem

A number of large investors have recently modified their holdings of XYL. Bruce G. Allen Investments LLC purchased a new stake in shares of Xylem during the 4th quarter valued at about $27,000. Coppell Advisory Solutions LLC purchased a new stake in shares of Xylem during the 2nd quarter valued at about $45,000. KB Financial Partners LLC purchased a new stake in shares of Xylem during the 1st quarter valued at about $42,000. ST Germain D J Co. Inc. purchased a new stake in shares of Xylem during the 2nd quarter valued at about $46,000. Finally, NBC Securities Inc. purchased a new stake in shares of Xylem during the 3rd quarter valued at about $38,000. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.